NDA 076182 describes OFLOXACIN, which is a drug marketed by
Bedford,
Altaire Pharms Inc,
Alvogen,
Amneal,
Apotex Inc,
Bausch And Lomb,
Epic Pharma Llc,
Fdc Ltd,
Mankind Pharma,
Sandoz,
Sentiss,
Caplin,
Hikma,
Cadila Pharms Ltd,
Dr Reddys Labs Ltd,
Larken Labs,
Ranbaxy Labs Ltd, and
Teva, and is included in twenty-six NDAs. It is available from
twenty-five suppliers. Additional details are available on the
OFLOXACIN profile page.
The generic ingredient in OFLOXACIN is
ofloxacin. There are seventy-eight
drug master file entries for this compound. Twenty-six
suppliers are listed for this compound. Additional details are available on the
ofloxacin profile page.